Who owns Ultragenyx Pharmaceutical Inc.?
Institutional ownership of RARE from SEC Form 13F filings across 205 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
205
13F holders
$2.03B
value, 2026 filers
63.5%
of shares outstanding (62.6M sh)
36
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30· % of fund = share of the manager's own book · % of co. = share of RARE's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 10.7M | $355.7M | 0.0% | 10.8% | +46.0% |
| 2 | VANGUARD PORTFOLIO MANAGEMENT LLC | 6.8M | $226.7M | 0.0% | 6.9% | +26.1% |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 4.3M | $143.5M | 0.0% | 4.4% | -48.7% |
| 4 | TWO SIGMA INVESTMENTS, LP | 3.6M | $120.9M | 0.1% | 3.7% | +64.2% |
| 5 | SANDS CAPITAL MANAGEMENT, LLC | 3.2M | $105.5M | 0.4% | 3.2% | -1.7% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 2.6M | $86.1M | 0.0% | 2.6% | +39.4% |
| 7 | D. E. Shaw & Co., Inc. | 1.7M | $57.8M | 0.0% | 1.8% | +37.2% |
| 8 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.6M | $52.8M | 0.1% | 1.6% | +229.2% |
| 9 | PRICE T ROWE ASSOCIATES INC /MD/ | 1.4M | $45,295 | 0.0% | 1.4% | +68.7% |
| 10 | MORGAN STANLEY | 1.3M | $44.2M | 0.0% | 1.3% | -11.7% |
| 11 | WELLINGTON MANAGEMENT GROUP LLP | 1.3M | $41.8M | 0.0% | 1.3% | -52.6% |
| 12 | BANK OF AMERICA CORP /DE/ | 1.1M | $38.3M | 0.0% | 1.2% | +9.7% |
| 13 | Candriam S.C.A. | 1.0M | $33.4M | 0.2% | 1% | -8.6% |
| 14 | NORTHERN TRUST CORP | 920,314 | $30.7M | 0.0% | 0.9% | +71.8% |
| 15 | Qube Research & Technologies Ltd | 882,219 | $29.5M | 0.0% | 0.9% | -3.6% |
| 16 | Russell Investments Group, Ltd. | 784,099 | $26.2M | 0.0% | 0.8% | +94.6% |
| 17 | MILLENNIUM MANAGEMENT LLC | 760,825 | $25.4M | 0.0% | 0.8% | -57.1% |
| 18 | Sixth Street Partners Management Company, L.P.NEW | 760,039 | $25.4M | 4.4% | 0.8% | new |
| 19 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 760,039 | $25.4M | 0.0% | 0.8% | +36.1% |
| 20 | Pictet Asset Management Holding SA | 753,695 | $23.2M | 0.0% | 0.8% | +24.9% |
| 21 | Nuveen, LLC | 693,959 | $23.2M | 0.0% | 0.7% | +4.8% |
| 22 | VANGUARD FIDUCIARY TRUST CO | 671,411 | $22.4M | 0.0% | 0.7% | +10.4% |
| 23 | UBS Group AG | 657,699 | $22.0M | 0.0% | 0.7% | -21.0% |
| 24 | Legal & General Group Plc | 586,520 | $19.6M | 0.0% | 0.6% | -0.6% |
| 25 | FMR LLC | 576,849 | $19.3M | 0.0% | 0.6% | +100.8% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.